Cardiovascular Comorbidities of Type 2 Diabetes Mellitus: Defining the Potential of Glucagonlike peptide–1-Based Therapies
| Autor: | Chilton, Robert, Wyatt, Jamison, Nandish, Shailesh, Oliveros, Rene, Lujan, Michael |
|---|---|
| Zdroj: | In The American Journal of Medicine 2011 124(1) Supplement:S35-S53 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|